ONMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Onemednet Corp (ONMD) is not a strong buy at this time for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of significant positive catalysts, weak technical indicators, and mixed financial performance make it prudent to hold off on investing in this stock currently.
The MACD is negative and expanding, suggesting bearish momentum. RSI is neutral at 51.593, indicating no clear trend. Moving averages are converging, showing no strong directional bias. The pre-market price is down 2.39%, and the stock is trading near its pivot level of 0.871, with key support at 0.807 and resistance at 0.935.
Revenue increased significantly by 3326.92% YoY in Q4 2025, showing strong top-line growth.
Net income remains negative at -$3,105,000, despite a 30.79% YoY improvement. EPS dropped by 25% YoY, and gross margin fell to 18.52%, down 118.52% YoY. No recent news or significant trading trends from hedge funds or insiders. Technical indicators suggest bearish momentum, and there are no strong buy signals from Intellectia Proprietary Trading Signals.
In Q4 2025, revenue grew significantly by 3326.92% YoY to $891,000, but the company remains unprofitable with a net loss of -$3,105,000. EPS dropped by 25% YoY to -0.06, and gross margin declined significantly to 18.52%, down 118.52% YoY.
No analyst rating or price target data available for ONMD.
